CTOs on the Move

MIVI Neuroscience

www.mivineuro.com

 
MIVI Neuroscience, (MIVI) is an innovative medical device company that aims to achieve life-giving results for an increasing number of patients experiencing acute ischemic stroke (AIS).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.mivineuro.com
  • 6545 City West Parkway
    Eden Prairie, MN USA 55344
  • Phone: 952.944.3834

Executives

Name Title Contact Details
Matt Ogle
Chief Technology Officer Profile

Funding

MIVI Neuroscience raised $45M on 12/29/2020
MIVI Neuroscience raised $35M on 01/21/2021

Similar Companies

HealthMedia

HealthMedia is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bleep Sleep

Fewer than 50% of Sleep Apnea patients stick with a CPAP solution – including us. So we decided to do something about it. Not sleeping sucks. Not sleeping and spending a fortune on CPAP devices that leak, fall off or leave marks on your face sucks even worse. That`s why we invented the DreamPort Sleep Solution – the world`s first-ever maskless CPAP device. The result is the smallest, lightest, most ergonomically accommodating CPAP solution on the market – a device that fits comfortably and doesn`t restrict your movement – enabling patients to get a better night`s sleep. Our goal is simple – to make the best bleeping CPAP products on the planet. We won`t stop until every sleep apnea patient is sleeping like a baby.

KPI Ultrasound

KPI Ultrasound LLC is a Riverside, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

KDA Triglav Systems

KDA Triglav Systems Ltd is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lensar

LENSAR, Inc. is a global leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision, accuracy, and efficiency while optimizing overall visual outcomes. LENSAR`s proprietary Augmented Reality technology -- reconstructed 3-D imaging, measurement, and guidance system -- offers quick and easy patient docking and provides high-resolution ocular images in a single scan. This technology facilitates enhanced procedure outcomes by allowing the physician to develop individualized treatment plans including precise laser delivery, and efficient lens fragmentation that can reduce, and potentially eliminate phaco energy. The LENSAR Laser System also offers the industry`s smallest laser footprint and thoughtful ergonomic design that accommodates most operating rooms. The LENSAR Laser System has been cleared by FDA for anterior capsulotomy, lens fragmentation, and corneal and arcuate incisions. For other indications it is an investigational device limited by U.S. law to investigational use only